Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
102.87
+0.49 (0.48%)
At close: Apr 2, 2026, 4:00 PM EDT
103.56
+0.69 (0.67%)
After-hours: Apr 2, 2026, 7:53 PM EDT
Abbott Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 |
Net Income | 1,776 | 1,644 | 1,779 | 1,325 | 9,229 | 1,646 | 1,302 | 1,225 | 1,594 | 1,436 | 1,375 | 1,318 | 1,033 | 1,435 | 2,018 | 2,447 | 1,989 | 2,100 | 1,189 | 1,793 |
Depreciation & Amortization | 792 | 791 | 777 | 756 | 807 | 801 | 805 | 805 | 813 | 824 | 800 | 806 | 807 | 815 | 822 | 823 | 883 | 847 | 874 | 934 |
Stock-Based Compensation | 113 | 120 | 142 | 289 | 111 | 117 | 141 | 304 | 114 | 117 | 132 | 281 | 115 | 123 | 142 | 305 | 106 | 114 | 132 | 288 |
Change in Receivables | 222 | -202 | -410 | -262 | -158 | -57 | -325 | -151 | 68 | -461 | -196 | 233 | 341 | 530 | -188 | -751 | -189 | -394 | 35 | 165 |
Changes in Inventories | 234 | 213 | 3 | -255 | 235 | 220 | -103 | -410 | 295 | 140 | -248 | -419 | -189 | -194 | -476 | -554 | 15 | 71 | -5 | -537 |
Changes in Other Operating Activities | - | 221 | -244 | -436 | - | -22 | 140 | -748 | - | -179 | -660 | -1,076 | - | 71 | 92 | -205 | - | -37 | -97 | -6 |
Operating Cash Flow | 3,315 | 2,787 | 2,047 | 1,417 | 2,868 | 2,705 | 1,960 | 1,025 | 3,038 | 1,877 | 1,203 | 1,143 | 2,326 | 2,780 | 2,410 | 2,065 | 3,067 | 2,701 | 2,128 | 2,637 |
Operating Cash Flow Growth | 15.59% | 3.03% | 4.44% | 38.24% | -5.60% | 44.11% | 62.93% | -10.32% | 30.61% | -32.48% | -50.08% | -44.65% | -24.16% | 2.93% | 13.25% | -21.69% | -19.25% | 30.74% | 60.97% | 268.81% |
Capital Expenditures | -689 | -496 | -502 | -484 | -720 | -556 | -533 | -398 | -755 | -560 | -507 | -380 | -610 | -467 | -379 | -321 | -614 | -461 | -413 | -397 |
Proceeds from Sale of Investments | -43 | 90 | -52 | 8 | 19 | -40 | 77 | -28 | 88 | -38 | 79 | -86 | 155 | -21 | 59 | -41 | 104 | -108 | 95 | -14 |
Payments for Business Acquisitions | -20 | -55 | -15 | - | - | - | - | - | 0 | -51 | -413 | - | - | - | - | - | 0 | -172 | 0 | -15 |
Proceeds from Business Divestments | - | - | - | - | 0 | 0 | 0.5 | - | 0 | 0 | 20 | - | 0 | 0 | 24 | - | 0 | 86 | 24 | - |
Other Investing Activities | 6 | 4 | 2 | 6 | 4 | 2 | 2 | 1 | 2 | 15 | 1 | 4 | 8 | 4 | 8 | 2 | 12 | 4 | 6 | 4 |
Investing Cash Flow | -913 | -457 | -582 | -470 | -866 | -594 | -453 | -425 | -824 | -634 | -1,213 | -462 | -632 | -484 | -264 | -360 | -671 | -651 | -264 | -422 |
Long-Term Debt Issued | 2 | 0 | 2 | 1 | 1 | 1 | 221 | - | 1 | 0 | 0.5 | - | 0 | 1 | 3 | - | 4 | 0 | - | - |
Long-Term Debt Repaid | -1 | -501 | -1 | -1,001 | -640 | -2 | -18 | - | -1,051 | -1,445 | -1 | - | 0 | -1 | -1 | -751 | -3 | -40 | -3 | -2 |
Net Long-Term Debt Issued (Repaid) | 1 | -501 | 1 | -1,000 | -639 | -1 | 203 | - | -1,050 | -1,445 | -0.5 | - | 0 | 0 | 2 | -751 | 1 | -40 | -3 | -2 |
Issuance of Common Stock | 5 | 69 | 35 | 287 | 25 | 92 | 13 | 134 | 34 | 56 | 15 | 62 | 41 | 57 | 10 | 59 | 82 | 70 | 17 | 86 |
Repurchase of Common Stock | -302 | -305 | -6 | -280 | -315 | -751 | -3 | -226 | -259 | -2 | -426 | -540 | -685 | -798 | -5 | -2,307 | -974 | -579 | -471 | -275 |
Net Common Stock Issued (Repurchased) | -297 | -236 | 29 | 7 | -290 | -659 | 10 | -92 | -225 | 54 | -411 | -478 | -644 | -741 | 5 | -2,248 | -892 | -509 | -454 | -189 |
Common Dividends Paid | -1,030 | -1,031 | -1,029 | -1,026 | -958 | -960 | -961 | -957 | -888 | -888 | -890 | -890 | -823 | -826 | -828 | -832 | -798 | -801 | -803 | -800 |
Other Financing Activities | -71 | 8 | -57 | -36 | 26 | 44 | -43 | -127 | 111 | -61 | 13 | -42 | 10 | 24 | 5 | 8 | -197 | -27 | -4 | 24 |
Financing Cash Flow | -1,397 | -1,760 | -1,097 | -2,055 | -1,861 | -1,576 | -791 | -1,176 | -2,052 | -2,340 | -1,289 | -1,410 | -1,457 | -1,543 | -813 | -3,823 | -1,886 | -1,377 | -1,264 | -967 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 6 | -10 | 51 | 24 | -83 | 36 | -13 | -36 | 25 | -29 | -27 | 8 | 51 | -96 | -71 | -6 | -13 | -29 | 4 | -32 |
Net Cash Flow | 1,011 | 560 | 419 | -1,084 | 58 | 571 | 703 | -612 | 187 | -1,126 | -1,326 | -721 | 288 | 657 | 1,262 | -2,124 | 497 | 644 | 604 | 1,216 |
Free Cash Flow | 2,626 | 2,291 | 1,545 | 933 | 2,148 | 2,149 | 1,427 | 627 | 2,283 | 1,317 | 696 | 763 | 1,716 | 2,313 | 2,031 | 1,744 | 2,453 | 2,240 | 1,715 | 2,240 |
Free Cash Flow Growth | 22.25% | 6.61% | 8.27% | 48.80% | -5.91% | 63.17% | 105.03% | -17.82% | 33.04% | -43.06% | -65.73% | -56.25% | -30.04% | 3.26% | 18.43% | -22.14% | -21.35% | 42.68% | 152.21% | 530.99% |
FCF Margin | 22.92% | 20.15% | 13.87% | 9.01% | 19.57% | 20.21% | 13.75% | 6.29% | 22.29% | 12.98% | 6.98% | 7.83% | 17.01% | 22.22% | 18.04% | 14.66% | 21.39% | 20.50% | 16.78% | 21.42% |
Free Cash Flow Per Share | 1.50 | 1.31 | 0.88 | 0.53 | 1.23 | 1.23 | 0.81 | 0.36 | 1.31 | 0.75 | 0.40 | 0.44 | 0.97 | 1.31 | 1.15 | 0.98 | 1.38 | 1.25 | 0.96 | 1.25 |
Levered Free Cash Flow | 2,114 | 1,872 | 1,814 | -94 | 8,912 | 2,088 | 1,814 | 474 | 897 | 216 | 759.5 | 249 | 1,041 | 1,660 | 2,079 | 1,439 | 2,274 | 2,480 | 1,545 | 1,785 |
Unlevered Free Cash Flow | 2,032 | 2,280 | 1,732 | 842.66 | 9,010 | 2,020 | 1,661 | 431.35 | 1,934 | 1,640 | 681 | 204.28 | 1,028 | 1,670 | 2,098 | 2,221 | 2,317 | 2,565 | 1,587 | 1,845 |
Updated Jan 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.